Advisory Boards and Councils
The Alliance's advisory boards and councils comprise leaders in medicine, research, health equity, young-onset CRC, media, and more. Members provide invaluable strategic support, counsel, and action in the mission to end colorectal cancer.
Medical Scientific Advisory Committee
The Colorectal Cancer Alliance Medical Scientific Advisory Committee advises the organization on new treatments, medications, research, and other key issues related to this disease.
Never Too Young Taskforce
Through local and national efforts, the Never Too Young Taskforce raises awareness about young-onset colorectal cancer and seeks to remove the stigma associated with the disease.
Learn More
LEAD FROM BEHIND Advisory Board
A new coalition is forming. Led by the Colorectal Cancer Alliance, colon cancer activists and survivors are teaming up with people across entertainment, sports, media, philanthropy, and tech to rebrand colon cancer and make it famous. The purpose of this effort is to develop a new brand that is culturally relevant, ultimately changing the way we talk about this disease, breaking stigma, making conversations about cancer prevention mainstream, and driving those aged 35-59 to take screening seriously.
Black Outreach Subcommittee for Screening (BOSS) Taskforce
The Black Outreach Subcommittee for Screening, Access, and Advocacy Taskforce (BOSS) is an affinity group of the Colorectal Cancer Alliance. The task force is a critical support in achieving our mission goals by addressing the disparate impact of colorectal cancer in the Black community, increasing awareness, and improving access to screening and supportive solutions for patients, families, caregivers, and survivors during and after diagnosis.
Top resources
Legislation introduced to address young-onset CRC
Explore the urgent need for the Colorectal Cancer Early Detection Act (HR 7714), legislation aimed at combating the rising incidence of colorectal cancer among younger adults through enhanced screening, education, and research.
EPIC Act to Advance New CRC Therapies Needs Support
The EPIC Act would encourage investment in clinical trials for additional uses of existing drugs.
Cousins to Rev Down Route 66 for a Reason
In a remarkable blend of adventure and advocacy, cousins John, Mitch, and Mike are gearing up for a cross-country charity journey along Route 66. Their mission? To raise awareness and support for two important causes: cystic fibrosis and colorectal cancer.